CTSO - Cytosorbents GAAP EPS of -$0.64 misses by $0.02 revenue of $31.09M misses by $6.4M
2024-03-14 17:09:01 ET
More on Cytosorbents
- Dawson James sees Cytosorbents' Cytosorb as approvable, but raises risk
- CytoSorbents drops as blood purification system fails key trial
- Seeking Alpha’s Quant Rating on Cytosorbents
- Historical earnings data for Cytosorbents
- Financial information for Cytosorbents